The muscle mitogen-activated protein kinase is altered in sporadic inclusion body myositis

Neurology. 2000 Apr 25;54(8):1665-70. doi: 10.1212/wnl.54.8.1665.

Abstract

Objective: To examine the origin of hyperphosphorylated proteins within the vacuolated myofibers in sporadic inclusion body myositis (s-IBM) and search for dysregulated intracellular protein phosphorylation.

Background: s-IBM is morphologically characterized by primary endomysial inflammation and vacuolated myofibers containing tubulofilaments that originate from cytoskeletal proteins. Mitogen-activated protein kinases (MAPKs) play a role in regulating phosphorylation and maintaining the stability of the cytoskeletal architecture.

Methods: Muscle biopsies from seven patients with s-IBM and 15 controls were examined for the expression of the active components of the various MAPKs, including p44/42MAPK, p38MAPK, p46JNK1, p54JNK2, and p54JNK3, using immunocytochemistry and Western blot analysis. The expression of selected phosphorylated components was also examined in the same specimens.

Results: In s-IBM, but not the disease controls, the vacuolated muscle fibers express active p42MAPK but not JNK or p38MAPK. Western blots of cell lysates confirmed the hyperexpression of p42MAPK and demonstrated a novel 35 kD phosphoprotein. Antibodies against phosphoepitopes of the 35 kD protein preferentially immunostained antigens within the vacuolated muscle fibers of s-IBM but not disease controls.

Conclusion: In s-IBM, there is increased p42MAPK activation and abnormal intracellular protein phosphorylation with selective accumulation of a 35 kD phosphoprotein within the vacuolated fibers. Although the hyperexpression of 35kD protein may represent cytoskeletal by-products due to heightened p42MAPK activation, its abundant expression only in s-IBM implies that hyperphosphorylated myofibrillar proteins may be involved in the primary disease process.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Aged
  • Animals
  • Biopsy
  • Blotting, Western
  • Cytoskeletal Proteins / biosynthesis
  • Epidermal Growth Factor / metabolism
  • Epidermal Growth Factor / pharmacology
  • Fluorescent Antibody Technique, Indirect
  • Humans
  • Immunohistochemistry
  • Middle Aged
  • Mitogen-Activated Protein Kinases / metabolism*
  • Muscle Fibers, Skeletal / enzymology
  • Muscle Fibers, Skeletal / pathology
  • Muscle, Skeletal / enzymology*
  • Muscle, Skeletal / pathology
  • Myositis, Inclusion Body / enzymology*
  • Myositis, Inclusion Body / pathology
  • PC12 Cells / drug effects
  • PC12 Cells / enzymology
  • Phosphorylation
  • Phosphoserine / metabolism
  • Rats
  • Vacuoles / metabolism

Substances

  • Cytoskeletal Proteins
  • Phosphoserine
  • Epidermal Growth Factor
  • Mitogen-Activated Protein Kinases